If you are interested in speaking at Machine Learning & AI in Healthcare, please contact:
Healthcare Conference Network
Phone: +1 (832) 709-0098
Professor of Psychology, University of Texas at Austin
Art Markman, Ph.D. is the Annabel Irion Worsham Centennial Professor of Psychology and Marketing at the University of Texas at Austin and founding Director of the Program in the Human Dimensions of Organizations. He is one of the world’s premier cognitive scientists and has written more than 150 scholarly papers on topics including reasoning, decision making, motivation, and innovation.
He brings insights about the human mind to companies around the world through his talks and his blogs at Psychology Today, Fast Company and Inc, as well as his radio show and podcast, Two Guys on Your Head. Art is the author of several books including Smart Thinking, Smart Change, Habits of Leadership and Brain Briefs.
Art routinely speaks about how to maximize mental agility, how to change behavior and influence others, how to make organizations more innovative and how to create a harmonious work environment that improves employee motivation.
Executive Director - Center for Health Systems Innovation (CHSI), Oklahoma State University
Prior to joining Oklahoma State University, Dr. Paiva was a partner at Sevin Rosen Funds, a venture capital fund with more than $2 billion under management. He was also a partner at Chisholm Private Capital Partners and the Oklahoma Life Science Fund. Dr. Paiva specialized in identifying early-stage venture opportunities at the intersection of traditional technology sectors and healthcare. Before his venture capital career, Dr. Paiva worked in management consulting at Pittiglio Rabin Todd & McGrath and as an investment banking associate at JP Morgan in New York.
Dr. Paiva holds a Ph.D. in molecular biology from the University of Oklahoma; an MBA from Dartmouth College’s Amos Tuck School of Business.
Nirmal Keshava, Ph.D.
Sr. Principal Informatics Scientist, AstraZeneca
Nirmal Keshava is a Senior Principal Informatics Scientist in Waltham, MA where he introduced analytics and machine learning in AstraZeneca for optimizing clinical trials, drug repurposing, precision medicine, translational oncology, pharmacovigilance, and wearable sensing. In 2014 he was a fellow in the Department of Clinical Informatics at Harvard Medical School. He has supervised several theses at MIT and Harvard in biomedical signal processing and clinical informatics.
Previously, at Draper Laboratory in Cambridge, MA, he led a research group developing novel biomedical algorithms. He was a Co-PI along with Harvard University on a Congressionally Directed Medical Research Program to develop neuroimaging algorithms to distinguish PTSD from mild TBI in veterans returning from combat. He was also a PI for several government programs to combine multiple physiological sensors to detect different cognitive states. Earlier, he was with MIT Lincoln Laboratory and Bell Communications Research.
He has a doctorate in electrical engineering from Carnegie Mellon University and a bachelor’s degree in from UCLA. He is a Senior Member of the IEEE, and in 2011 he was recognized by the National Academy of Engineering as one of the top young engineers in the United States. He has several journal and conference publications, 2 patents pending, and will organize the industry track for the 2018 IEEE Biomedical and Health Informatics Conference
Ajay K. Gupta
Chief Executive Officer, Health Solutions Research
Mr. Gupta is a seasoned Cybersecurity and health IT professional, well versed and experienced in GIS systems as well as in outcomes- and treatment-based data analysis on public health data and information systems.
Through his research into public health issues as diverse as personal health records, EMR/EHR systems, hospital-provider value-based contracting, data analytics in healthcare, aging-in-place, care-giving, digital imaging for telehealth applications and medical transportation systems, he has developed a keen understanding of the challenges facing and policy considerations for public health.
John Zaleski PhD, CAP, CPHIMS
Chief Analytics Officer, Bernoulli Enterprise
John Zaleski, PhD, CAP, CPHIMS, is Chief Analytics Officer of Bernoulli Enterprise, Inc. (http://bernoullihealth.com), a leader in real-time connected healthcare. Dr. Zaleski brings 21 years of experience in researching and ushering to market devices and products to improve healthcare. He received his Ph.D. from the University of Pennsylvania, with a dissertation that describes a novel approach for modeling and prediction of post-operative respiratory behavior in post-surgical cardiac patients. Dr. Zaleski has a particular expertise in designing, developing, and implementing clinical and non-clinical point-of-care applications for hospital enterprises. Dr. Zaleski is the named inventor or co-inventor on seven issued U.S. patents related to medical device interoperability ad clinical informatics. He is the author of numerous peer-reviewed articles and conference papers on clinical use of medical device data, information technology and medical devices and wrote three seminal books on integrating medical device data into electronic health records and the use of medical device data for clinical decision making, including the #1 best seller of HIMSS 2015 on connected medical devices.
Associate Professor, Johns Hopkins School of Medicine
Jim Fackler M.D. is interested in operations research within Pediatric Critical Care focused on task analyses, modeling and redistribution of all tasks to the right provider (regardless of current historical, cultural and/or regulatory constraints). He was on the faculty of the Children’s Hospital Boston for about 10 years before returning to Hopkins in 1996.
Academic interests also include data integration. He is a founding Board Member of the Virtual PICU. With medical device and physiological data, he is mentoring Masters and Ph.D. students in data visualization, pattern recognition and guideline adherence. He co-chairs the Machine Learning for Healthcare meeting that will be in Boston in August 2017. www.mucmd.org
On the corporate side, Dr. Fackler worked for the Cerner Corporation from 2002-2006. He was responsible for the development and deployment of the critical care solution suite. From 2009-2014 he had a part-time role for Cardiopulmonary Corporation; a data integration, analytical and alarm management company. He recently founded a new company focused on team performance optimization in the pediatric critical care environment.
Dr. Patrick Tyler
Resident Physician: Internal Medicine, Beth Israel Deaconess Medical Center
Dr. Patrick Tyler is a senior resident in the Department of Internal Medicine at the Beth Israel Deaconess Medical Center (Boston, MA) and a Clinical Fellow in Medicine at Harvard Medical School. His research focuses on secondary analysis of health records as part of the Massachusetts Institute of Technology (MIT) Critical Data, a consortium of investigators using the Medical Information Mart in Intensive Care (MIMIC) database.
Director, Biomedical Cybernetics Laboratory
Gil Alterovitz is Director of the Biomedical Cybernetics Laboratory and a Harvard professor with the Computational Health Informatics Program at Boston Children’s Hospital and the Harvard/MIT Division of Health Sciences and Technology. His work on integrative informatics methods, including applications in drug discovery, has been published or presented in approximately 50 peer-reviewed publications and three books (including “Systems Bioinformatics: An Engineering Case-based Approach,” ranked #1 in new Amazon bioinformatics category). A large component of Dr. Alterovitz’s work involves international collaborations that bring together researchers and work on heterogeneous clinico-genomic data.
His work involves leading clinical genomics standards and development. He serves as co-chair of the HL7 Clinical Genomics workgroup (where he is group leader of the FHIR Genomics effort), is on the executive team of the Clinical Workgroup of the Global Alliance for Genomics and Health (GA4GH), and serves as a member of the Institute of Medicine DIGITizE project. Within the SMART consortium, he leads the SMART/FHIR Genomics effort. He was recently also appointed to the national Precision Medicine Task Force and to lead the Sync for Genes effort for enabling a national standard for sharing of clinical genomic information.
Alterovitz has been recognized for innovation by several awards (e.g. Epstein award by the American Medical Informatics Association and the Motorola Intellectual Property Award). His lab’s work has previously been recognized by the White House, National Institutes of Health, Office of the National Coordinator and other government agencies. Dr. Alterovitz has appeared and cited on various national and international news and media outlets such as USA Today, National Public Radio/WBUR, Canada’s CBC radio, and Spain’s El Mundo for his research.
He received a Fulbright to Canada early in his career and later named as a Fulbright Scholar to do research in genomics the U.K. He was also selected as one of approximately 20 international delegates to Canada25 (to discuss healthcare/technology) to put together a policy paper that was covered internationally. He was invited to be one of the key panelists in the BEF 2013 (Babson Entrepreneurial Forum) to discuss “Gazing into the Crystal Ball: Opportunities in the Next Decade.”
A large component of Dr. Alterovitz’s work involves international components. Dr. Alterovitz has a joint faculty appointment with Shanghai Jiao Tong University and has had NIH/NSFC-funded collaborations at Fudan University (China). He is dedicated to his students’ academic success and learning. He has served as a PhD/masters advisor mentor for students from several institutions such as Harvard, MIT, Boston University, and Northeastern University in Boston and internationally in Asia: National University of Singapore, Xian Jiao Tong University (China), The University of Science and Technology of China, National Taiwan University, National Chiao Tung University (Taiwan), Indian Institute of Technology Delhi, Vignana Bharathi Institute of Technology (India) and others.
Chess Stetson, Ph.D. is the CEO of Helynx, an AI company that has joined forces with Apollo Medical to reduce costs and improve patient outcomes. Dr. Stetson did his doctoral (2012) and post-doctoral work in Computation and Neural Systems at Caltech, studying the oscillatory relationship between cortical regions and applying machine learning to signals from individual neurons to predict decisions. Previously, he studied the basis of neural time processing, including the first ever experimental test of the idea that your perception of time changes during fearful scenarios. He earned an AB in Physics from Harvard College, (2001) and an MS from the University of Texas (Houston Medical Center, 2006). He also worked as an engineer at MIT Lincoln Laboratory and the Smithsonian Astrophysical Observatory, building instrumentation for air- and rocket-borne experiments. He sometimes appears as a scientific expert on National Geographic’s “Brain Games.”
Dr. Luis Bermudez
Executive Director: Innovation Program, Open Geospatial Consortium
Dr. Luis Bermudez is the Executive Director of the Innovation and the Compliance programs at the Open Geospatial Consortium(OGC). The OGC is the world leading standards consortium advancing geospatial technologies to make it easier sharing of location data. The Innovation Program, provides a collaborative agile process bringing together geospatial technology users for advancing new technologies and standards. Under the Compliance Program, Dr. Bermudez leads the development of open source web validation tools that have supported hundreds of implementations to comply with OGC standards.
Dr. Bermudez has a Ph.D. and M.S. in Environmental Informatics from Drexel University. He has more than 20 years of experience in the information and technology industry including geospatial, sensor web, semantic web, data analytics and legal information. Dr. Bermudez is also an adjunct faculty member in the Master of Professional Studies in Geographic Information Systems program at the University of Maryland, where he teaches topics on GIS, databases, NoSQL, cloud computing and cartographic modeling.
Prior to joining the OGC in 2010, he was the Technical Manager for the SURA Coastal Ocean Observing and Prediction Program and Technical Lead at the Monterey Bay Aquarium Research Institute (MBARI). In both positions, he advanced solutions implemented world-wide to support management and sharing of ocean observing systems. In Colombia (1996-1999), he developed CRM and legal information systems, and provided consulting on strategic planning and technology implementation for Latin America companies.
His hobby is learning about personal growth and motivate people about how to become great on what they do and achieve their dreams.
Dr. Ram Peruvemba
Chief Medical Officer, Health Solutions Research
Dr. Peruvemba, a practicing Anaesthesiologist and Pain Management Specialist licensed in Maryland (D0055800) and Virginia, is an expert in Health IT as well as in the clinical, regulatory, and policy issues surrounding healthcare. He is a member of the MedChi Board and serves on the HSCRC Advisory Council.
Assistant Professor of Emergency Medicine, Brigham and Women's Hospital, Harvard Medical School
Ziad Obermeyer is an assistant professor of emergency medicine at Brigham & Women’s Hospital and assistant professor of healthcare policy at Harvard Medical School. He is a faculty affiliate of the Harvard Institute for Quantitative Social Science and Ariadne Labs at the Harvard School of Public Health.
His research combines insights from clinical medicine with methods from biostatistics, computer science, and econometrics, to translate large observational datasets into meaningful inferences at the patient and provider levels. His major areas of work are:
Unexpected death after medical encounters: measuring the quality of emergency care and identifying the weak points in clinical diagnostics and health systems that make adverse events more likely
- Expected deaths and end of life care: understanding how palliative and hospice care affect health care utilization and costs, and what drives choice of end of life care at the individual doctor and patient level
- Predictive analytics: applying machine learning to make predictions on health outcomes using large observational datasets, with the goal of improving clinical decision making and population health management
- Emergency care in low- and middle-income countries: collecting and improving data collection on the delivery of emergency care, in the countries where it is most needed
He holds a BA (magna cum laude) from Harvard and an MPhil from Cambridge, where he was a Frank Knox fellow in the history and philosophy of science. He worked as a consultant to pharmaceutical and global health clients at McKinsey & Co. in New Jersey, Geneva, and Tokyo before returning to Harvard for his MD (magna cum laude). While a medical student, he worked as a full-time research scientist at the Institute for Health Metrics and Evaluation at the University of Washington, supported by the Bill & Melinda Gates Foundation. He completed his clinical residency in emergency medicine at the Brigham & Women’s, Massachusetts General, and Boston Children’s Hospitals. He is the recipient of a 2012 Early Independence Award from the High Risk–High Reward Portfolio of the Office of the Director of the National Institutes of Health and the Young Investigator Award for the Society for Academic Emergency Medicine. Currently, he has received grant support from Robert Wood Johnson, the World Bank Group, and the Laura and John Arnold Foundation.
Anand Iyer Ph.D.
Chief Strategy Officer, WellDoc
With more than 12 years of experience in digital health, Dr. Anand K. Iyer is one of the most respected global leaders in this space for his insights and experience on technology, strategy, and regulatory policy. Prior to joining WellDoc in 2007, he was a partner at and led the wireless strategy practice at PRTM Management Consultants for 15 years, and was a pioneer in telematics & telemetry, RFID policy, mobile business strategy development, network engineering and economic modeling. In 2013, he was honored as Maryland Healthcare Innovator of the year, and in 2007, as one of the top 35 global wireless executives.
He was also the founder and immediate-past president of the In-Building Wireless Alliance, and teaches advanced wireless courses to senior officers in the US Department of Defense at the Institute for Defense and Business. Prior to joining PRTM, Anand was a member of the scientific staff at Bell Northern Research and Nortel Networks. Anand holds a MS and PhD in electrical and computer engineering, and an MBA from Carnegie Mellon University, and a BE degree in electrical and computer engineering from Carleton University.
Vice President of Big Data Analytics, REAN Cloud
Larry provides more than two decades of technology, product and consulting practice leadership as the VP of REAN Cloud’s Big Data Analytics group. He served in multiple roles at data science company Sentrana. Larry led the migration of a custom application onto Amazon Web Services, and led teams of data scientists building custom machine learning solutions. Finally, he provided product management leadership for cloud native Big Data and machine learning tools based on AWS and open source technologies.
In previous positions Larry served as a consultant at Gartner providing technology strategy and architecture services for government, healthcare, higher education and financial services clients. He developed the IT security and IAM practice for Gartner, and led the integration of the Burton Group consultants and their intellectual property in 2010.
Dr. Wayne West
Senior Vice President and Chief Technologist, Crivella West Technologies, Inc.
Wayne West is the Co-founder, Senior Vice President and Chief Technologist of Crivella West Technologies, Inc. (“CW Tech”) and of Crivella West Decision Analytics, Inc. (“CW Analytics”). Mr. West and his partner, Arthur Crivella, have 30 years’ experience as businessmen, designers, inventors and engineers, modernizing and improving business and information system processes for a number of the world’s largest commercial and professional enterprises.
West and Crivella are recognized as industry leaders for their innovations in the areas of business process design, improvement, restructuring and strategic planning. Their accomplishments include patented inventions that have shaped the way the internet is used for business commerce, process management and education. Mr West and his partner have leveraged their entrepreneurial skills to launch a number of successful companies to commercialize their inventions, improving the operational and financial effectiveness of leading companies and law firms, higher education, military and government organizations.
Notable career accomplishments for Messrs West and Crivella include projects supporting capital investments of more than $1 billion for clients, such as US Steel, Goodyear Tire and Rubber Company, Corning Asahi Video Products and the United States Marine Corps. Crivella and West’s projects helped Goodyear to win the Chrysler Award for “Superiority and Excellence of Product Quality,” and Corning to win both the Lead Award for the Society of Manufacturing Engineers and the Malcolm Baldrige National Quality Award.
Mr. West’s principal areas of expertise as chief science officer include automated text and language analytics; decision support systems design; technology assessment; and management of computer integrated manufacturing systems design and implementation.
Prior to co-founding the companies, Mr. West held engineering positions with Dravo Engineering, Computer Integrated Manufacturing Group, Westinghouse, Instrumentation and Controls Group and Babcock & Wilcox. He holds a Bachelor’s degree in Nuclear Engineering from Pennsylvania State University.
Chief Data Scientist, Intermedix
Damian Mingle is Chief Data Scientist for Intermedix, a global leader pioneering innovations in data analytics and cloud-based technology to deliver best-in-class revenue cycle management, practice management, and emergency management solutions. In this role Mr. Mingle works with a team of experts to extract knowledge from data. Prior to Intermedix Mr. Mingle held positions with companies like WPC Healthcare, Hospital Corporation of America (HCA), Coventry Healthcare (an Aetna Company), and Morgan Stanley.
As a leading authority on healthcare data science, Mr. Mingle speaks nationally and internationally on patient safety, global health, and applied data science. His current board service includes the Neural Network and JUMP. Mr. Mingle’s work has been published in The International Clinical Pathology Journal, Current Trends in Biomedical Engineering & Biosciences, and The International Journal of Biomedical Data Mining.
He is ranked in the top 1 percent globally as a data scientist through regular competitions. Mr. Mingle was the 2015 NTC Data Scientist of the Year, 2016 Sepsis Hero Finalist, and the 2017 Best Use of AI in Food, Health, and Medicine for machine learning innovation in the Emergency Department.
Mr. Mingle is married, has three daughters, and lives in Franklin, TN.
Chief Innovation Officer, Pathway Genomics
Dr. Nova is currently the Chief Innovation Officer of Pathway Genomics, and was a founding team member of the company. He is the inventor of the Pathway-IBM/Watson Machine Learning A.I. mobile application: Panorama/OME; and the entire Wellness (Pathway FIT/Healthy Weight, SkinFIT), Cardiac and Mental Health line of genetic testing products for Pathway. Dr Nova has executed major corporate alliances with companies such as CVS, Sony, Medco/ESI, PepsiCo, DASA (Brazil), Biogenetika (Brazil), Achibadem (Turkey), IHH/Parkway (Singapore), IBM, Florida Hospital Group, Equinox Health, and many others. His scientific career began as a research associate at the Salk Institute in the laboratory of Nobel Laureate Roger Guillemin, where he studied the genetics and proteomics of human growth factors and cancers. Michael was previously the founder and CEO of Discovery Partners Inc. (Nasdaq: DPII), which completed a successful $150M IPO and marketed wireless drug discovery technology and radiofrequency combinatorial chemistry to large pharmaceutical companies. Intellectual property developed by Dr. Nova at DPII included the original “barcode on bead” patents used by many diagnostic and DNA companies. He then founded the wireless sensory network company Graviton, where he was responsible for raising $60 million in capital from venture groups such as Kleiner Perkins, InQtel and large corporations such as Motorola and Qualcomm. Dr. Nova is also the 2005 World Economic Forum (WEF) Technology Pioneer Award Winner; and the physician of record on the first person ever to have their entire genome sequenced by Illumina (2009).
He is a member of the IBM Watson Advisory Board, the Metagenics Scientific Advisory Board, the Salk Institute NeuroAI group, and the Longevity Org Advisory Board. Michael has given 100’s of seminars, talks, and interviews at venues around the world on subjects including genetics, machine learning, and mobile big data.
Dr. Nova has over 30 issued, and 45 pending patents; and he has numerous publications in peer-reviewed journals. With degree’s in Biochemistry, Computer Science, and Medicine, Dr. Nova is a Board-certified Dermatopathologist licensed in California. In his minimal spare time, Michael likes to surf big waves in Indonesia and Mexico, and he also helped build a WHO-sanctioned basic care clinic in the Fijian town of Nabila.
Director - Business Strategies Emerging Technologies & Strategic Partnerships , AHA's Institute For Precision Cardiovascular Medicine
Executive Director, Healthcare and Life Sciences, REAN Cloud
Application Development Engineer, REAN Cloud
Dr. Linda Zeger
Founder and Principal Consultant , Auroral
Dr. Linda M. Zeger’s experience includes consulting, research and development, program management, and teaching. She has published numerous papers in journals and conferences across several disciplines and is the holder of a number of U.S. and foreign patents. Dr. Zeger is the founder and principal consultant of Auroral LLC, which provides research and development and consulting services in data analytics, modeling, and performance analysis. Dr. Zeger is also a visiting research professor at Florida Polytechnic University. Previously, Dr. Zeger has held positions at MIT Lincoln Laboratory, Lucent Technologies Bell Laboratories, and Educational Testing Services. Dr. Zeger holds a Ph.D. in physics from Harvard University.
Dr. Zeger specializes in data analytics, statistical modeling, system design, and performance evaluation, which she has applied to a broad range of technical disciplines including health care, education, communication networks, and information dissemination and security. Through investigations she has conducted in these domains, she has designed and developed innovative techniques to analyze and improve performance in various types of systems, for example by optimizing experimental designs, strengthening network communication resiliency, and increasing efficiency in resource allocation. The performance improvements enabled by these studies include more accurate and shorter assessments, increased data reliability, and reduction in time and energy for data dissemination.